Earnings Call · Q3 FY2023·2023-11-02

Q3 23EPS +21.43%·Rev n/aQ2 23EPS +42.86%·Rev n/aQ1 23EPS +100.00%*·Rev n/aQ4 22EPS -100.00%*·Rev n/a⚠ consensus missing

PUMA BIOTECHNOLOGY, INC. PBYI

Mariann Ohanesian — Senior Director of Investor Relations

Alan Auerbach — Chief Executive Officer, President and Chairman of the Board

Jeff Ludwig — Commercial Leader

Maximo Nougues — Chief Financial Officer

+11.6%1d on move date+10.7% vs SPY3d+16.5%5d+32.9%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PBYI calls or request research access.

More PBYI calls Browse calls Request research access